| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |